State of New Jersey Common Pension Fund D’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
53,040
+6,804
| +15% | +$247K | 0.01% | 1222 |
|
|
2025
Q1 | $1.67M | Sell |
46,236
-278
| -0.6% | -$10.1K | 0.01% | 1352 |
|
|
2024
Q4 | $1.96M | Buy |
46,514
+11,745
| +34% | +$494K | 0.01% | 1308 |
|
|
2024
Q3 | $1.93M | Sell |
34,769
-13,995
| -29% | -$777K | 0.01% | 1362 |
|
|
2024
Q2 | $2M | Sell |
48,764
-6,721
| -12% | -$276K | 0.01% | 1003 |
|
|
2024
Q1 | $2.59M | Sell |
55,485
-9,583
| -15% | -$447K | 0.01% | 1452 |
|
|
2023
Q4 | $3.11M | Sell |
65,068
-3,269
| -5% | -$156K | 0.01% | 954 |
|
|
2023
Q3 | $2.44M | Buy |
68,337
+18,045
| +36% | +$643K | 0.01% | 1101 |
|
|
2023
Q2 | $2.32M | Hold |
50,292
| – | – | 0.01% | 1494 |
|
|
2023
Q1 | $2.02M | Sell |
50,292
-17,049
| -25% | -$684K | 0.01% | 1466 |
|
|
2022
Q4 | $3.12M | Buy |
67,341
+20,052
| +42% | +$929K | 0.01% | 834 |
|
|
2022
Q3 | $1.96M | Hold |
47,289
| – | – | 0.01% | 1436 |
|
|
2022
Q2 | $2.82M | Buy |
47,289
+2,951
| +7% | +$176K | 0.01% | 893 |
|
|
2022
Q1 | $3.22M | Buy |
44,338
+2,054
| +5% | +$149K | 0.01% | 951 |
|
|
2021
Q4 | $3.56M | Buy |
42,284
+152
| +0.4% | +$12.8K | 0.01% | 920 |
|
|
2021
Q3 | $3.8M | Buy |
42,132
+2,562
| +6% | +$231K | 0.01% | 869 |
|
|
2021
Q2 | $3.77M | Buy |
39,570
+1,210
| +3% | +$115K | 0.01% | 890 |
|
|
2021
Q1 | $4.37M | Buy |
38,360
+305
| +0.8% | +$34.7K | 0.02% | 808 |
|
|
2020
Q4 | $5.27M | Sell |
38,055
-2,549
| -6% | -$353K | 0.02% | 684 |
|
|
2020
Q3 | $3.34M | Sell |
40,604
-492
| -1% | -$40.4K | 0.01% | 832 |
|
|
2020
Q2 | $3.22M | Sell |
41,096
-17,848
| -30% | -$1.4M | 0.01% | 847 |
|
|
2020
Q1 | $2.62M | Hold |
58,944
| – | – | 0.01% | 860 |
|
|
2019
Q4 | $2.52M | Buy |
58,944
+13,144
| +29% | +$561K | 0.01% | 1180 |
|
|
2019
Q3 | $1.96M | Buy |
45,800
+36,400
| +387% | +$1.56M | 0.01% | 1410 |
|
|
2019
Q2 | $597K | Hold |
9,400
| – | – | ﹤0.01% | 867 |
|
|
2019
Q1 | $652K | Hold |
9,400
| – | – | ﹤0.01% | 856 |
|
|
2018
Q4 | $409K | Hold |
9,400
| – | – | ﹤0.01% | 878 |
|
|
2018
Q3 | $718K | Hold |
9,400
| – | – | ﹤0.01% | 869 |
|
|
2018
Q2 | $723K | Hold |
9,400
| – | – | ﹤0.01% | 896 |
|
|
2018
Q1 | $479K | Hold |
9,400
| – | – | ﹤0.01% | 906 |
|
|
2017
Q4 | $436K | Hold |
9,400
| – | – | ﹤0.01% | 894 |
|
|
2017
Q3 | $501K | Hold |
9,400
| – | – | ﹤0.01% | 899 |
|
|
2017
Q2 | $584K | Hold |
9,400
| – | – | ﹤0.01% | 874 |
|
|
2017
Q1 | $637K | Hold |
9,400
| – | – | ﹤0.01% | 867 |
|
|
2016
Q4 | $661K | Hold |
9,400
| – | – | ﹤0.01% | 856 |
|
|
2016
Q3 | $667K | Hold |
9,400
| – | – | ﹤0.01% | 852 |
|
|
2016
Q2 | $460K | Hold |
9,400
| – | – | ﹤0.01% | 878 |
|
|
2016
Q1 | $595K | Hold |
9,400
| – | – | ﹤0.01% | 870 |
|
|
2015
Q4 | $1.05M | Hold |
9,400
| – | – | ﹤0.01% | 838 |
|
|
2015
Q3 | $905K | Hold |
9,400
| – | – | ﹤0.01% | 852 |
|
|
2015
Q2 | $962K | Hold |
9,400
| – | – | ﹤0.01% | 842 |
|
|
2015
Q1 | $584K | Hold |
9,400
| – | – | ﹤0.01% | 891 |
|
|
2014
Q4 | $412K | Hold |
9,400
| – | – | ﹤0.01% | 925 |
|
|
2014
Q3 | $532K | Hold |
9,400
| – | – | ﹤0.01% | 886 |
|
|
2014
Q2 | $422K | Buy |
+9,400
| New | +$422K | ﹤0.01% | 888 |
|